SCHEMBL27844158

SCHEMBL27844158

CC(C)(C)OC(=O)Cn1ccc2cc(C#N)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ TSHR P16473 4/20 0.43
▸ HSD17B10 Q99714 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ GLA P06280 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ USP2 O75604 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ ABCB1 P08183 1/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.40
▸ PRMT5 O14744 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ FFAR4 Q5NUL3 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PPARD Q03181 2/20 0.38
▸ P2RX7 Q99572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467553 0.88 KDM4E (0.41) NPY5RALDH1A1KDM4ETSHRHSD17B10
SCHEMBL8029435 0.86 ATM (0.53) NPY5RALDH1A1KDM4ETSHRHSD17B10
SCHEMBL2470686 0.84 MAPT (0.48) NPY5RALDH1A1KDM4ETSHRHSD17B10
SCHEMBL23810852 0.81 NTSR1 (0.51) HDAC6ATMROCK2
SCHEMBL13836584 0.81 NTSR1 (0.51) ALDH1A1KDM4EHDAC6ATMROCK2
SCHEMBL9009161 0.80 MTNR1A (0.47) NPY5RALDH1A1KDM4ETSHRHSD17B10
SCHEMBL3465527 0.80 KMT2A (0.55) NPY5RALDH1A1KDM4ETSHRHSD17B10
SCHEMBL5069199 0.80 PLA2G4A (0.55) KDM4EHDAC6ATMROCK2PPARD
SCHEMBL19470070 0.79 PLA2G4A (0.43) ALDH1A1KDM4EHSD17B10HPGDPOLB
SCHEMBL1435785 0.78 NPY5R (0.42) NPY5RALDH1A1KDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102245602-B Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis MERCK SERONO SA 2014-09-10 — — CN disclosed
CN-102245602-A Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis MERCK SERONO SA 2011-11-16 — — CN disclosed
Send feedback